Ignite Creation Date:
2024-05-05 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00290043
Status:
COMPLETED
Last Update Posted:
2010-12-06
First Post:
2006-02-09
Brief Title:
Glulisine Pre- and Postmeal
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Glucodynamic Response to Pre- and Postmeal Subcutaneous Injection of 015 IUkg HMR1964 Insulin and RHI in Type 1 Diabetic Subjects in an Open Randomized Four-way Crossover Study
Status:
COMPLETED
Status Verified Date:
2010-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate in type 1 diabetic patients the glucodynamic response to HMR1964 insulin and RHI HOE31HPR100 injected subcutaneously before and after a standard meal
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| HMR1964 | None | None | None |